Shares of Cogent Biosciences, Inc. (NASDAQ:COGT – Get Free Report) have earned a consensus recommendation of “Moderate Buy” from the seven research firms that are currently covering the firm, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback